Dongfang Liu's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 150,000 Class A Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 01 Dec 2025 | 150,000 | 168,000 | - | 2.9 | 439,500 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 150,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 01 Dec 2025 | 150,000 | 18,000 | - | 7.8 | 1,173,255 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.61 per share. | 25 Nov 2025 | 10,000 | 28,000 | - | 3.6 | 36,100 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 10,000 | 470,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 10,000 | 480,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 25 Nov 2025 | 10,000 | 18,000 | - | 8 | 80,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.61 per share. | 25 Nov 2025 | 10,000 | 28,000 | - | 3.6 | 36,100 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 25 Nov 2025 | 10,000 | 18,000 | - | 7.5 | 75,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 20 Nov 2025 | 20,000 | 18,000 | - | 7.0 | 140,074 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 20 Nov 2025 | 20,000 | 38,000 | - | 1.9 | 37,400 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 17 Nov 2025 | 15,000 | 30,000 | - | 1.9 | 28,050 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 15,000 | 470,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 15,000 | 485,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 17 Nov 2025 | 15,000 | 18,000 | - | 5.1 | 76,553 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 17 Nov 2025 | 15,000 | 30,000 | - | 1.9 | 28,050 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.76 per share. | 17 Nov 2025 | 15,000 | 15,000 | - | 4.8 | 71,475 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 20,000 | 480,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 02 May 2025 | 20,000 | 12,000 | - | 2.5 | 50,024 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 02 May 2025 | 20,000 | 32,000 | - | 1.9 | 38,800 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 315,000 | 315,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 490,000 | 490,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 292,500 | 292,500 | - | - | Stock Option (Right to Buy) |